Eprodisate for the treatment of renal disease in AA amyloidosis.

Abstract

BACKGROUND Amyloid A (AA) amyloidosis is a complication of chronic inflammatory conditions that develops when proteolytic fragments of serum amyloid A protein (SAA) are deposited in tissues as amyloid fibrils. Amyloid deposition in the kidney causes progressive deterioration in renal function. Eprodisate is a member of a new class of compounds designed to… (More)

Topics

5 Figures and Tables

Blog articles referencing this paper

Slides referencing similar topics